{
  "success": true,
  "sourceFile": "C:\\Users\\panik\\Documents\\GitHub\\Protcol2USDMv3\\input\\trial\\NCT02460978_REWIND\\NCT02460978_REWIND_SAP.pdf",
  "pagesUsed": [
    0,
    1,
    2,
    3,
    4,
    5,
    6,
    7,
    8,
    9,
    10,
    11,
    12,
    13,
    14,
    15,
    16,
    17,
    18,
    19,
    20,
    21,
    22,
    23,
    24,
    25,
    26,
    27,
    28,
    29,
    30,
    31,
    32,
    33,
    34,
    35,
    36,
    37,
    38,
    39
  ],
  "modelUsed": "gemini-3-flash-preview",
  "sapData": {
    "analysisPopulations": [
      {
        "id": "pop_1",
        "name": "Enrolled subjects dataset",
        "text": "The enrolled subjects dataset will consist of all subjects who signed the informed consent form.",
        "populationType": "Other",
        "instanceType": "AnalysisPopulation",
        "label": "Enrolled",
        "populationDescription": "The enrolled subjects dataset will consist of all subjects who signed the informed consent form.",
        "criteria": "Signed informed consent form"
      },
      {
        "id": "pop_2",
        "name": "Lead-in subjects dataset",
        "text": "The lead-in subjects dataset will consist of all subjects who entered the lead-in period.",
        "populationType": "Other",
        "instanceType": "AnalysisPopulation",
        "label": "Lead-in",
        "populationDescription": "The lead-in subjects dataset will consist of all subjects who entered the lead-in period.",
        "criteria": "Entered the lead-in period"
      },
      {
        "id": "pop_3",
        "name": "Full analysis dataset",
        "text": "The full analysis dataset will consist of all randomized subjects who received at least one dose of double-blind study medication during the short-term double-blind treatment period.",
        "populationType": "Efficacy",
        "instanceType": "AnalysisPopulation",
        "label": "FAS",
        "populationDescription": "The full analysis dataset will consist of all randomized subjects who received at least one dose of double-blind study medication during the short-term double-blind treatment period.",
        "criteria": "Randomized AND received >=1 dose of double-blind study medication"
      },
      {
        "id": "pop_4",
        "name": "Evaluable subjects dataset",
        "text": "The evaluable subjects dataset will consist of all subjects in the full analysis dataset who did not have any relevant protocol deviations.",
        "populationType": "Efficacy",
        "instanceType": "AnalysisPopulation",
        "label": "Evaluable",
        "populationDescription": "The evaluable subjects dataset will consist of all subjects in the full analysis dataset who did not have any relevant protocol deviations.",
        "criteria": "Included in FAS AND no relevant protocol deviations"
      },
      {
        "id": "pop_5",
        "name": "Treated subjects dataset",
        "text": "The treated subjects dataset will consist of all subjects who received at least one dose of double-blind study medication during the short-term double-blind treatment period.",
        "populationType": "Safety",
        "instanceType": "AnalysisPopulation",
        "label": "Treated",
        "populationDescription": "The treated subjects dataset will consist of all subjects who received at least one dose of double-blind study medication during the short-term double-blind treatment period.",
        "criteria": "Received >=1 dose of double-blind study medication"
      }
    ],
    "characteristics": [
      {
        "id": "char_1",
        "name": "HbA1c",
        "code": "HBA1C",
        "codeSystem": "http://www.cdisc.org/baseline-characteristics",
        "codeSystemVersion": "2024-03-29",
        "decode": "HbA1c",
        "dataType": "Numeric",
        "instanceType": "Characteristic",
        "description": "Glycosylated Hemoglobin at baseline"
      },
      {
        "id": "char_2",
        "name": "Body Weight",
        "code": "BODY_WEIGHT",
        "codeSystem": "http://www.cdisc.org/baseline-characteristics",
        "codeSystemVersion": "2024-03-29",
        "decode": "Body Weight",
        "dataType": "Numeric",
        "instanceType": "Characteristic",
        "description": "Subject weight at baseline"
      },
      {
        "id": "char_3",
        "name": "Total Daily Insulin Dose",
        "code": "TOTAL_DAILY_INSULIN_",
        "codeSystem": "http://www.cdisc.org/baseline-characteristics",
        "codeSystemVersion": "2024-03-29",
        "decode": "Total Daily Insulin Dose",
        "dataType": "Numeric",
        "instanceType": "Characteristic",
        "description": "The total amount of insulin used by the subject per day"
      },
      {
        "id": "char_4",
        "name": "Method of insulin administration",
        "code": "METHOD_OF_INSULIN_AD",
        "codeSystem": "http://www.cdisc.org/baseline-characteristics",
        "codeSystemVersion": "2024-03-29",
        "decode": "Method of insulin administration",
        "dataType": "Categorical",
        "instanceType": "Characteristic",
        "description": "Categorized as Multiple Daily Injections (MDI) or Continuous Subcutaneous Insulin Infusion (CSII)"
      }
    ],
    "summary": {
      "populationCount": 5,
      "characteristicCount": 4
    }
  }
}